|
|
Volumn 46, Issue 2, 2012, Pages 238-263
|
|
Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 PHENYLBUTYRIC ACID;
AMBRISENTAN;
AMIFOSTINE;
ANAGRELIDE;
BLOOD CLOTTING FACTOR 9;
CARGLUMIC ACID;
FOSPHENYTOIN SODIUM;
GALLIUM;
GANCICLOVIR;
LEVACETYLMETHADOL;
ORPHAN DRUG;
PROTEIN C;
RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE;
VELAGLUCERASE ALFA;
DRUG APPROVAL;
DRUG CLASSIFICATION;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
HUMAN;
LEGAL ASPECT;
NAGS DEFICIENCY;
POLICY;
PRIORITY JOURNAL;
STANDARD;
|
|
EID: 84864118282
PISSN: 00928615
EISSN: None
Source Type: Journal
DOI: 10.1177/0092861511435906 Document Type: Editorial |
|
Times cited : (42)
|
|
References (0)
|
